The role of the endothelium in the short-term complications of hematopoietic SCT
90Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party
Apheresis days required for harvesting CD34 + cells predicts hematopoietic recovery and survival following autologous transplantation
Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID
Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT
Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies
A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality
Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled study
Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells
Expression of CD64 (FcγRI) in skin of patients with acute GVHD
Inherent problems of comparing second and third remission in patients with acute lymphoblastic leukemia
Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes for children with B-precursor ALL and early or late BM relapse
Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT
Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL
Alemtuzumab as salvage therapy for steroid and ATG/etanercept-refractory acute GVHD
Successful hematopoietic SCT from non-identical twins to two sisters with b-thalassemia major by using preimplantation genetic diagnosis and HLA typing
Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT
Combining allografting with mTOR inhibitors for metastatic renal cell cancer
Romiplostim (AMG531, Nplate) for secondary failure of platelet recovery after allo-SCT
Blood and marrow transplant handbook: comprehensive guide for patient care